Tag: Monoclonal antibodies

Therapeutic effect of anti-IL-12/IL-23 p40 on experimental autoimmune uveitis and its mechanism

·Experimental Research· Therapeutic effect of anti-IL-12/IL-23 p40 on experimental autoimmune uveitis and associated mechanism Cui Xuexue, Zhang Zhihui, Wu Lingzi, Li Yongtao, Chen Shuang, Chen Nu, Zhang Xiaomin Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University […]

Inhibitory effect of RMT1-10-induced tolerogenic dendritic cells in vitro on high-risk corneal allograft rejection in mice and its mechanism

Authors: Zhao Min,  Yang Liuqing,  Wang Mengyu,  Tao Yu,  Guo Yongyue,  Su Ruifeng,  Shi Jing,  Tan Xiaobo DOI: 10.3760/cma.j.cn115989-20201228-00868 Published 2022-08-10 Cite asChin J Exp Ophthalmol, 2022, 40(8): 725-733. Abstract                                       [View PDF] [Read Full Text] Objective To investigate the inhibitory effect of […]

Comparison of therapeutic effect for diabetic macular edema based on different optical coherence tomography patterns

Authors: Xu Xinyu,  Xia Ying,  Hu Tianming,  Wei Wei DOI: 10.3760/cma.j.cn115989-20190606-00247 Published 2021-11-10 Cite asChin J Exp Ophthalmol, 2021, 39(11): 975-981. Abstract                              [View PDF] [Read Full Text] Objective To evaluate the efficacy of intravitreal ranibizumab (IVR) injection and/or laser photocoagulation on diabetic macular edema (DME) […]

Preventive effect of intravitreal injection of ranibizumab on rehaemorrhagia following vitrectomy for prolifarative diabetic retinopathy

Authors: Ma Lie,  Li Xiaoxin DOI: 10.3760/cma.j.issn.2095-0160.2017.01.014 Published 2017-01-10 Cite as Chin J Exp Ophthalmol, 2017,35(1): 69-72. Abstract                              [Download PDF] [Read Full Text] Background Vitrectomy is a primary approach to the treatment of proliferative diabetic retinopathy (PDR). However, postoperative rehaemorrhagia often occur.Ranibizumab is […]